
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Today, ComEd, together with its community partners, announced $2.5 million in new bill assistance that will soon be available to help eligible business custome

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

/PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of

NEW YORK, May 29, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 29, 2026, has a record date of June 15, 2026, and has an ex-date of June 15, 2026.

NEW YORK, April 30, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on May 29, 2026, has a record date of May 15, 2026, and has an ex-date of May 15, 2026.

NEW YORK, April 20, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced today the final results of its transferable rights offering (the "Offer"), which expired at 5:00 P.M. Eastern Time on April 15, 2026 (the "Expiration Date").

The Neuberger High Yield Strategies Fund offers a headline 16.66% yield, the highest among closed-end junk bond peers. NHS is not covering its distribution with investment income, as net asset value has declined 10.22% over two years, signaling unsustainable payouts. The fund's portfolio is concentrated in BB and B-rated high-yield bonds, balancing risk and income but sacrificing some yield versus lower-rated debt.

NEW YORK, April 16, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced today the preliminary results of its transferable rights offering (the "Offer"), which commenced on March 23, 2026 and expired on April 15, 2026 (the "Expiration Date"). Pursuant to the Offer, the Fund issued one transferable right (a "Right") for each share of common stock of the Fund ("Common Stock") held by stockholders of record as of March 23, 2026.

Novo Nordisk stock surged on Wednesday after a major policy win, which is seen as a turning point for the drugmaker. England's cost-effectiveness watchdog has backed broader use of Wegovy to cut the risk of heart attacks and strokes in overweight or obese adults.

Eli Lilly wants the UK to regularly raise NHS drug prices and phase out a multi-billion-pound rebate scheme if it is to resume investment, its international businesses president Patrik Jonsson told the Financial Times.

NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced approval of the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common stock (par value $0.0001 per share) ("Common Stock"), as of the record date, March 23, 2026 (the "Record Date"). Holders of these Rights will be entitled to subscribe for additional shares of Common Stock (the "Offer") at a discount to market price.

NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced an early declaration of the Fund's regular monthly distribution payable in April. The $0.0905 per share of common stock distribution announced today is payable on April 30, 2026, has a record date of April 7, 2026, and has an ex-date of April 7, 2026.
